Interaction of Respiratory Dendritic cells with Influenza Virus Infection in vitro (43.44)

Abstract

Abstract Influenza A virus is a major cause of infection of the respiratory tract worldwide. Approximately 10–20% of U.S. population is estimated to be infected by this virus each year. Respiratory tract dendritic cells (RDC) are believed to play a major role as antigen presenting cells in initiating adaptive immune response to influenza virus infection. We have examined the effect of influenza virus infection of purified RDC in vitro at different MOI (Multiplicity of Infection) on virus protein expression, co-stimulatory molecules expression, and cytokines production. We found that there is not only an MOI dependent increase in the percentage of infected RDC, but also the infection of RDC at high MOI results in higher level and accelerated viral protein synthesis at early time post infection. Production of tested cytokines and chemokines by RDC increases with increasing of MOI except for IL-12 p40. Furthermore, we found that at high MOI total RDCs can be divided to several populations based on CD40 and influenza nucleoprotein (NP) expression: CD40high NPlow, CD40low NPhigh, and CD40negNPnegDCs. In conclusion, our results suggest that there is a diverse response of RDC to influenza virus at different MOI as reflected by their susceptibility to infection and cytokine production. These results may provide insight into how RDC modulate host response in the lung to influenza virus infection. (Support: USPHS grant, NIH AI-15608, HL-33391,HL-71875)